| Exec date | Filing date | Company | Role | Signal | Confidence | Shares | % of shares | Under plan? | Amount (USD) |
|---|---|---|---|---|---|---|---|---|---|
| Sep 15, 2023 | Sep 28, 2023 | OKYO Pharma Ltd | Director | Buy | 91.3 | +16,670 | 100.00% | ✗ | $25K |
| Mar 22, 2021 | Mar 22, 2021 | Cardiff Oncology, Inc. | Director | Buy | 91.3 | +3,000 | 32.40% | ✗ | $32.9K |
| Dec 2, 2020 | Dec 2, 2020 | Hepion Pharmaceuticals, Inc. | Director | Buy | 91.3 | +7,000 | 87500.00% | ✗ | $10.7K |
| May 14, 2020 | May 18, 2020 | Cardiff Oncology, Inc. | Director | Buy | 90.0 | +6,993 | 308.47% | ✗ | $10K |
| Jun 8, 2018 | Jun 13, 2018 | Cardiff Oncology, Inc. | Director | Buy | 90.0 | +10,000 | 277.93% | ✗ | $8K |
| Jun 8, 2018 | Jun 11, 2018 | Cardiff Oncology, Inc. | Director | Buy | 90.0 | +10,000 | 23.17% | ✗ | $8K |
| Mar 4, 2014 | Mar 7, 2014 | Hepion Pharmaceuticals, Inc. | Director | Buy | 90.0 | +4,393 | 218.01% | ✗ | $6.5K |